AUD 0.09
(-2.17%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 | 3.09 Million AUD | 13.11% |
2023 | 2.73 Million AUD | 292.38% |
2022 | 698.06 Thousand AUD | 153.61% |
2021 | 275.25 Thousand AUD | -36.63% |
2020 | 434.36 Thousand AUD | 70.55% |
2019 | 254.69 Thousand AUD | 11.59% |
2018 | 228.24 Thousand AUD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q3 | 618.19 Thousand AUD | -6.55% |
2024 Q2 | 661.55 Thousand AUD | -28.93% |
2024 FY | -579.78 Thousand AUD | -121.17% |
2024 Q1 | 930.85 Thousand AUD | 0.9% |
2024 Q4 | 307.71 Thousand AUD | 0.0% |
2023 FY | 2.73 Million AUD | 292.38% |
2023 Q4 | 922.52 Thousand AUD | 0.0% |
2023 Q3 | 922.52 Thousand AUD | 83.11% |
2023 Q2 | 503.81 Thousand AUD | 0.0% |
2023 Q1 | 503.81 Thousand AUD | 225.74% |
2022 Q3 | 154.66 Thousand AUD | -24.43% |
2022 FY | 698.06 Thousand AUD | 153.61% |
2022 Q2 | 204.66 Thousand AUD | 0.0% |
2022 Q1 | 204.66 Thousand AUD | 104.5% |
2022 Q4 | 154.66 Thousand AUD | 0.0% |
2021 Q4 | 100.08 Thousand AUD | 0.0% |
2021 FY | 275.25 Thousand AUD | -36.63% |
2021 Q1 | 37.54 Thousand AUD | -83.0% |
2021 Q2 | 37.54 Thousand AUD | -0.0% |
2021 Q3 | 100.08 Thousand AUD | 166.6% |
2020 Q3 | 220.89 Thousand AUD | 145225.66% |
2020 Q1 | 153.00 AUD | 0.0% |
2020 Q4 | 220.89 Thousand AUD | 0.0% |
2020 Q2 | 152.00 AUD | -0.65% |
2020 FY | 434.36 Thousand AUD | 70.55% |
2019 FY | 254.69 Thousand AUD | 11.59% |
2018 FY | 228.24 Thousand AUD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Australian Clinical Labs Limited | 247.36 Million AUD | 98.748% |
Genetic Signatures Limited | -16.2 Million AUD | 119.123% |
Genetic Technologies Limited | 3.9 Million AUD | 20.653% |
Healius Limited | 541.2 Million AUD | 99.428% |
Imagion Biosystems Limited | -3.88 Million AUD | 179.784% |
Integral Diagnostics Limited | 103.8 Million AUD | 97.015% |
INOVIQ Ltd | -989.82 Thousand AUD | 412.996% |
Microba Life Sciences Limited | -8.58 Million AUD | 136.099% |
Monash IVF Group Limited | 85.5 Million AUD | 96.376% |
Rhythm Biosciences Limited | -1.35 Million AUD | 328.242% |
Sonic Healthcare Limited | 2.33 Billion AUD | 99.867% |